Skeletal complications in mucopolysaccharidosis VI patients: Case reports

Journal of Pediatric Rehabilitation Medicine

Volumn 3, Issue 1, 2010, Pages 63-69

  Garcia, Paula ^a   Sousa, Sérgio B ^a   Ling, Tah Pu ^a   Conceiço, Mário ^a   Seabra, Jorge ^a   White, Klane K ^b   Diogo, Luisa ^a  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^b SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

Author keywords

Bone; Mucopolysaccharidosis VI; Orthopedics; Skeleton

Indexed keywords

GALSULFASE;

ARTICLE; CASE REPORT; CHILD; ENZYME REPLACEMENT; GENE MUTATION; HIP DISLOCATION; HIP DYSPLASIA; HUMAN; HYPOPLASIA; JOINT CONTRACTURE; JOINT STIFFNESS; KYPHOSIS; MALE; MAROTEAUX LAMY SYNDROME; OSTEOTOMY; PIGEON THORAX; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SCOLIOSIS; VERTEBRA HYPOPLASIA;

EID: 77953423498     PISSN: 18745393     EISSN: 18758894     Source Type: Journal    
DOI: 10.3233/PRM-2010-0108     Document Type: Article

References (18)

1. D. Auclair, J.J. Hopwood, D.A. Brooks, J.F. Lemontt and A.C. Crawley, Replacement therapy in Mucopolysaccharidosis type VI: advantages of early onset of therapy, Mol Genet Metab 78 (2003), 163-174.
2. P.J. Belmont, Jr. and D.W. Polly, Jr., Early diagnosis of Hurler's syndrome with the aid of the identification of the characteristic gibbus deformity, Mil Med 163 (1998), 711-714.
3. W.P. Blount and G.R. Clarke, Control of bone growth by epiphyseal stapling: a preliminary report, J Bone Joint Surg Am 31A (1949), 464-478.
4. S. Byers, J.D. Nuttall, A.C. Crawley, J.J. Hopwood, K. Smith and N.L. Fazzalari, Effect of enzyme replacement therapy on bone formation in a feline model of mucopolysaccharidosis type VI, Bone 21 (1997), 425-431. (Pubitemid 27485311)
5. M.A. Cleary and J.E. Wraith, The presenting features of mucopolysaccharidosis type IH (Hurler syndrome), Acta Paediatr 84 (1995), 337-339.
6. A.C. Crawley, K.H. Niedzielski, E.L. Isaac, R.C.A. Davey, S. Byers and J.J. Hopwood, Enzyme replacement therapy from birth in a feline model of mucopolysaccharidosis type VI, J Clin Invest 99 (1997), 651-662. (Pubitemid 27097666)
7. R. Giugliani, P. Harmatz and J.E. Wraith, Management guidelines for mucopolysaccharidosis VI, Pediatrics 120 (2007), 405-418.
8. P. Harmatz, C.B. Whitley, L. Waber, R. Pais, R. Steiner, B. Plecko, P. Kaplan, J. Simon, E. Butensky and J.J. Hopwood, Enzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux-Lamy syndrome), J Pediatr 144 (2004), 574-580.
9. P. Harmatz, C.B. Whitley, L. Waber, R. Pais, R. Steiner, B. Plecko, P. Kaplan, J. Simon, J. Waterson and J.J. Hopwood, A phase I/II study of enzyme replacement therapy (ERT) for mucoploysaccharidosis VI (MPS VI; maroteaux-lamy syndrome): 48 week progress report, Am J Hum Genet 71 (2002), 582.
10. P. Harmatz, D. Ketteridge, R. Giugliani, N. Guffon, E.L. Teles, M.C. Miranda, Z.F. Yu, S.J. Swiedler and J.J. Hopwood, Direct comparison of measures of endurance, mobility, and joint function during enzyme-replacement therapy of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): results after 48 weeks in a phase 2 open-label clinical study of recombinant human N-acetylgalactosamine 4-sulfatase, Pediatrics 115 (2005), e681-e689.
11. P. Harmatz, R. Giugliani, I. Schwartz, N. Guffon, E.L. Teles, M.C. Śa Miranda, J.E. Wraith, M. Beck, L. Arash, M. Scarpa, Z.F. Yu, J.Wittes, K.I. Berger, M.S. Newman and A.M. Lowe, Enzyme replacement therapy for mucopolysaccharidosis VI: a phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfataseBor rhASB) and follow-on, open-label extension study, J Pediatr 148 (2006), 533-539.
12. R. Lachman, K.W. Martin, S. Castro, M.A. Basto, A. Adams and E. Lẽao Teles, Radiologic and neuroradiologic findings in the mucopolysaccharidoses, Journal of Pediatric Rehabilitation Medicine, Submitted (reference to another paper of these proceedings).
13. E.F. Neufeld and J. Muenzer, The mucopolysaccharidoses, in: The Metabolic and Molecular Bases of Inherited Disease, C.R. Scriver, A.L. Beaudet, W.S. Sly and D. Valle, eds, McGraw- Hill Medical Publishing Division, New York, 2001, pp. 3421- 3452.
14. E. Odunusi, C. Peters, W. Krivit and J. Ogilvie, Genu valgum deformity in Hurler syndrome after hematopoietic stem cell transplantation: correction by surgical intervention, J Pediatr Orthop 19 (1999), 270-274.
15. M.F.G. Petry, T. Dieter, M. Burin, R. Giugliani and S. Leistner, Identification of a novel mutation in the ARSB gene that is frequent among Brazilian MPSVI patients, Genet Test 7 (2003), 347-349.
16. M. Scarpa, R. Barone, A. Fiumara, L. Astarita, G. Parenti, A. Rampazzo, S. Sala, G. Sorge and R. Parini, Mucopolysaccharidosis VI: the Italian experience, Eur J Pediatr 168 (2009), 1203-1206.
17. P.M. Stevens, Guided growth for angular correction: a preliminary series using a tension band plate, J Pediatr Orthop 27 (2007), 253-259.
18. J.A. Thorne, M. Javadpour, D.G. Hughes, E. Wraith and R.A. Cowie, Craniovertebral abnormalities in Type VI mucopolysaccharidosis (Maroteaux-Lamy syndrome), Neurosurgery 48 (2001), 849-852.